Navigation Links
PreMD Reports Fiscal 2007 Results
Date:3/28/2008
---------------------------------------------------------------------
-------------------------------------------------------------------------
PreMD Inc.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In Canadian dollars)
Years ended December 31
2007 2006 2005
$ $ $
-------------------------------------------------------------------------
OPERATING ACTIVITIES
Net loss and comprehensive
loss for the year (6,315,812) (5,948,971) (4,989,705)
Add (deduct) items not
involving cash
Amortization 165,753 319,205 256,260
Stock-based compensation
costs included in
Research and development
expense 193,527 156,920 147,085
General and administration
expense 400,821 383,767 421,812
Loss (gain) on sale of capital
assets 139,669 (1,743) -
Imputed interest on
convertible debentures 1,002,394 819,609 255,529
Mark-to-market adjustment
on derivative 18,000 - -
Interest on convertible
debentures paid in
common shares 543,312 281,462 -
Loss (gain) on foreign exchange (1,288,160) 97,748 (35,734)
Net change in non-cash working
capital balances related to
operations (1,011,237) 1,422,730 (1,061,397)
Increase (decrease) in deferred
revenue 480,060 (2,609,315) (301,885)
------------------------------
'/>"/>
| SOURCE PreMD Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. PreMD Provides Update on 510(k) Application for PREVU(x) POC
2. PreMD Inc. Provides Corporate Update
3. PreMD Announces Valuable Data on PREVU(x) LT Life Insurance Product
4. PreMD Announces FDA Decision on POC Skin Cholesterol Test
5. PreMD Initiates FDA Review Process and Provides Corporate Update
6. PreMD Inc. Announces Debenture Financing
7. PreMD Inc. Signs Agreement with Cosmetics Conglomerate
8. PreMD Inc. Completes Debenture Financing
9. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
10. Haemacure Reports Third Quarter 2007 Results
11. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
Post Your Comments:
(Date:5/24/2013)... commonly used to treat glaucoma may cause droopy eyelids ... according to a new study. The drugs, known ... eye pressure, have already been shown to cause blurred ... said, suggesting that the new findings could lead to ... conservative when prescribing these drugs, the researchers added, particularly ...
(Date:5/24/2013)... New York (PRWEB) May 24, 2013 Let’s ... teeth. It is not uncommon for the majority of people ... Whether it is due to a coffee addiction or simply ... why whitening procedures are so popular. , Herald ... new and very effective whitening system: Venus White Max. ...
(Date:5/24/2013)... 2013 Area homeowners dreaming about owning a ... tubs to choose from at factory-direct pricing during the ... event takes place at Emerald Pool and Patio ... Jacuzzi, the industry's leading hot tub brand, scheduled the event ... The event will feature popular hot tub models at up ...
(Date:5/24/2013)... May 24, 2013 The nation’s first ... Intuitive Surgical Inc.’s da Vinci Surgical System concluded yesterday, ... a Washington State Court jury ruled in a 10-to-2 ... a surgeon who performed a da Vinci prostatectomy on ... patient’s family had alleged in their lawsuit that the ...
(Date:5/24/2013)... infantile myofibromatosis (IM)a disorder characterized by multiple tumors involving ... targets, according to researchers from the Icahn School of ... American Journal of Human Genetics , may lead ... which the only current treatment option is repeated surgical ... disorder that develops in infancy or even in utero ...
Breaking Medicine News(10 mins):Health News:Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds 2Health News:Herald Square Dental Introduces New In-office Whitening System: Venus White Max 2Health News:Truckload of Jacuzzi® Hot Tubs Rolls into Bend, Oregon on May 24, 2013 for Sales Event 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications 3Health News:Researchers identify first drug targets in childhood genetic tumor disorder 2[0] Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds[0] Herald Square Dental Introduces New In-office Whitening System: Venus White Max[0] Truckload of Jacuzzi® Hot Tubs Rolls into Bend, Oregon on May 24, 2013 for Sales Event[0] Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications[0] Researchers identify first drug targets in childhood genetic tumor disorder
... transplantation reliably yield grafts for two adults? Experts consider ... the July issue of Liver Transplantation , a ... also available online at Wiley Interscience ( www.interscience.wiley.com ). ... advanced surgical strategies to increase opportunities for those in ...
... , ... ROUND ROCK, Texas (Business Wire EON) June 30, ... the mantra that ,more is better, when it comes to managing ... Life Sciences. "Virtualizing the IT infrastructure fully illustrates the idea that ...
... PLANTATION, Fla., June 30 To further growth ... service and,medical management operations, Broadspire has made several ... -- Dennis Replogle, currently chief executive officer, becomes ... currently president of Broadspire, also will,assume the responsibilities ...
... PRUSSIA, Pa., June 30 TMG Health announced,today that ... of the,Ernst & Young Entrepreneur Of The Year(R) 2008 ... the awards program was designed to,recognize outstanding entrepreneurs on ... leading dynamic, growing businesses. Jack Tighe,was selected as a ...
... Declaration Survey, SEOUL, Korea, June 30 ... the workplace and keeping,it top of mind with ... keeping employees safe, according to a DuPont-sponsored survey ... The survey results are the basis for the ...
... FORT WORTH, Texas, June 30 Wound Management,Technologies, ... signing,of a commission based, sales agreement for its ... (EWA GSI). This agreement,follows discussions and demonstrations, and ... role in international wound management.,CellerateRx patented collagen fragments ...
Cached Medicine News:Health News:Experts examine challenges of split liver transplantation 2Health News: Virtualization with Dell Helps Cure Growing Health Care IT Ills 2Health News: Virtualization with Dell Helps Cure Growing Health Care IT Ills 3Health News: Virtualization with Dell Helps Cure Growing Health Care IT Ills 4Health News:Broadspire Announces Key Leadership Appointments 2Health News:Broadspire Announces Key Leadership Appointments 3Health News:TMG Health President and CEO Jack Tighe Named Ernst & Young Entrepreneur Of The Year(R) 2008 in Philadelphia Region 2Health News:TMG Health President and CEO Jack Tighe Named Ernst & Young Entrepreneur Of The Year(R) 2008 in Philadelphia Region 3Health News:Companies Report Success in Driving Safety Culture at Workplaces 2Health News:Companies Report Success in Driving Safety Culture at Workplaces 3Health News:Companies Report Success in Driving Safety Culture at Workplaces 4Health News:Wound Management Technologies, Inc. Announces Sales Agreement with EWA Government Systems, Inc. 2Health News:Wound Management Technologies, Inc. Announces Sales Agreement with EWA Government Systems, Inc. 3Experts examine challenges of split liver transplantation Virtualization with Dell Helps Cure Growing Health Care IT Ills Broadspire Announces Key Leadership AppointmentsTMG Health President and CEO Jack Tighe Named Ernst & Young Entrepreneur Of The Year(R) 2008 in Philadelphia RegionCompanies Report Success in Driving Safety Culture at WorkplacesWound Management Technologies, Inc. Announces Sales Agreement with EWA Government Systems, Inc.
(Date:5/23/2013)... 2013 More than half of women diagnosed ... chemotherapy and still have excellent outcomes. To educate women, ... the largest sources of online consumer information about breast ... page provide recently diagnosed women with information sources, to ... "We anticipate these innovative social media campaigns ...
(Date:5/23/2013)... , May 23, 2013 Hologic, Inc. ... ), a leading developer, manufacturer and supplier of ... with an emphasis on serving the healthcare needs ... observational study in a U.S. clinical practice comparing ... (breast tomosynthesis) with conventional 2D mammography alone showed ...
(Date:5/23/2013)... BioElectronics Corporation (OTC Pink: BIEL), the maker of ... FDA panel meeting for non-thermal shortwave diathermy: ... Therapy Meeting was held on May 21, 2013 in ... of the meeting was very narrow, in that the ... the application of non-thermal shortwave diathermy for the treatment ...
Breaking Medicine Technology:Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4BioElectronics and Pulsed Shortwave Therapy Make Progress 2[0] Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions[0] First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection[0] BioElectronics and Pulsed Shortwave Therapy Make Progress
... , , , PORTLAND, ... administration of the H1N1 vaccine and to encourage members to ... costs associated with the administration of the H1N1 vaccine during ... members covered by its insured plans. Regence will strongly encourage ...
... , , , ... today from the COMPARE trial demonstrated that Abbott,s (NYSE: ... System demonstrated significantly better outcomes in key safety and efficacy ... (TAXUS). At one year, XIENCE V demonstrated a significantly lower ...
Cached Medicine Technology:Regence to Cover Administration Costs of H1N1 Vaccine for Fully-Insured Groups, Individuals This Flu Season 2Regence to Cover Administration Costs of H1N1 Vaccine for Fully-Insured Groups, Individuals This Flu Season 3Abbott's XIENCE V(R) Demonstrates Significantly Lower Rates of MACE and Stent Thrombosis Compared to TAXUS(R) Liberte in Investigator-Initiated COMPARE Trial 2Abbott's XIENCE V(R) Demonstrates Significantly Lower Rates of MACE and Stent Thrombosis Compared to TAXUS(R) Liberte in Investigator-Initiated COMPARE Trial 3Knot pusher/suture retriever...
Single step suture passage is made simple with Arthro-Pierce instruments. The low profile, highly sharpened tip allows easy passage through tissue in order to retrieve or apply suture....
Arthrex has the most extensive offering of arthroscopic suture passing instruments,available anywhere in the world. We have speci? cally designed the function of our,instruments to work hand in hand ...
Arthrex has the most extensive offering of arthroscopic suture passing instruments,available anywhere in the world. We have speci? cally designed the function of our,instruments to work hand in hand ...
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |